Sygnis Ag operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sygnis Ag with three other
companies in this sector in Germany:
sales of 2.06 million Euro [US$2.55 million]
Heidelberg Pharma Ag
(1.36 million Euro [US$1.69 million]
(1.54 million Euro [US$1.91 million]
Sales increased substantially in 2016:
During the year ended December of 2016, sales at
Sygnis Ag were 1.79 million Euro (US$2.21 million).
increase of 222.3%
versus 2015, when the company's sales were 555,000.00 Euro.
Sales of Other saw an increase
429.4% in 2016, from
303,000.00 Euro to 1.60 million Euro.
Not all segments of Sygnis Ag experienced an increase in sales in 2016:
sales of Licenses fell 26.6% to 185,000.00 Euro.